Stock Market
-
“Nomura’s Q1 Profit Plummets by 76% Amidst Global Banking Concerns in Japan”
Nomura Holdings Inc, Japan’s leading brokerage and investment bank, recently reported a staggering 76% decline in its quarterly net profit.…
Read More » -
Airbus Names New Chief for A320 Family Jet Program
According to industry sources, Airbus has made changes to the leadership of its A320-family jetliner programme, which is a major…
Read More » -
European equities dip as banking sector concerns persist
On Wednesday, European stock markets saw a dip as concerns about the health of the global banking system weighed heavily…
Read More » -
“Market Wrap-Up: S&P/ASX 200 Dips by 0.08% as Australian Stocks Close Lower”
On Wednesday, Australian stocks dipped as losses in the Utilities, Metals & Mining and Materials sectors dragged shares lower. The…
Read More » -
“Nikkei 225 Closes 0.71% Lower as Japan Stocks Dip”
Following the conclusion of Wednesday’s trading session, Japanese stocks took a hit, largely due to losses in the Steel, Banking,…
Read More » -
Reckitt surpasses sales forecasts and appoints Kris Licht as CEO
Reckitt Benckiser, the company behind popular brands like Durex, Lysol, and Nurofen, has announced that Kris Licht will be taking…
Read More » -
Starship prototype explodes shortly after liftoff during test flight led by Elon Musk
SpaceX’s Starship spacecraft exploded during an uncrewed test flight in South Texas on Thursday. The flight test marked the first…
Read More » -
“Glencore’s Pledge of a Higher Bid Intensifies Pressure on Teck Resources”
Glencore, the Swiss miner and trader, has informed Teck Resources shareholders of its readiness to enhance its takeover offer of…
Read More » -
ACEA Reports Over 1 Million Units of Passenger Car Sales in March, Marking a 28.8% Increase in EU
According to a report released by the European Automobile Manufacturers Association (ACEA) on Wednesday, passenger car registrations in the European…
Read More » -
GSK Invests $2 Billion in Bellus Health’s Cough Drug to Ease Pipeline Concerns
GlaxoSmithKline (GSK) is set to acquire Bellus Health, a Canadian drug developer, for $2 billion in cash as part of…
Read More »